Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: history of present illness: this is a 58-year-old male with metastatic renal cell carcinoma admitted for phase 1 and 2 trial of peg-intron with il-2 for advanced renal cell carcinoma. oncologic history: patient initially presented with asymptomatic hematuria in . biopsy revealed renal cell carcinoma and he underwent a radical nephrectomy. he subsequently underwent resection of two lesions of the left posterior lung also consistent with renal cell carcinoma. serial ct scans in revealed a solitary left kidney mass of 2 cm and subsequently underwent a left partial nephrectomy. he was enrolled in a phase iii adjuvant trial comparing il-2 with observation and randomized to the observation arm. a follow-up ct scan performed on showed evidence of increased metastatic disease with mediastinal lymphadenopathy, pulmonary nodules and increase size of the mass of lower pole of left kidney. mri confirmed the disease progression in the left kidney and pulmonary metastases. he is currently enrolled in a phase trial with outpatient peg-intron with il-2 for advanced renal cell carcinoma. past medical history: significant for hypertension. allergies: no known drug allergies. outpatient medications: norvasc 10 mg a day, zestril 40 mg po q.d., hydrochlorothiazide 25 mg po q.d. all his hypertensives have been held since hours, as well as tylenol po prn. social history: he is a former smoker and quit 20 years ago. he was employed as a machinist. he is married with three children and drinks a couple of glasses of wine at night. family history: father died of an myocardial infarction. mother hypertension. physical examination: height 63 inches. weight 76.5. body surface area 1.8 meters squared. ecog status 0-1. vital signs: blood pressure 150/90. heart rate 100. respiratory rate 20. temperature 98.5. 99% on room air. pleasant in no acute distress., head, eyes, ears, nose and throat: sclera were conjunctive. clear oropharynx, pink with exudate, no oral mucoid cutaneous lesions. neck: no anterior, posterior cervical lymphadenopathy. no supraclavicular axillary lymphadenopathy. lungs clear to auscultation in all fields. heart: regular rate and rhythm, no murmurs, rubs or gallops. abdomen soft, nontender, nondistended, active bowel sounds, no hepatosplenomegaly. extremities: no peripheral edema, no rashes. neurological: alert and oriented times three. cranial nerves ii through xii are grossly intact. laboratories: white blood cell count 5.8, hematocrit 40.4, platelets 214,000. sodium 135, potassium 4.2, chloride 97, bicarbonate 26, bun 17, creatinine 1.2, glucose 94, alt 17, ast 18, ldh 186, alkaline phosphatase 51, t bilirubin .71, calcium 9.4. hospital course: he was admitted on with a performance status of 0-1 to begin. he received il-2 at 5 million units per meter squared per dose q. 8 hours times three which equalled 9 million units subcutaneously. he also received his first dose of peg-intron at 2 mcg/kg per week equalling a dose of 153 mcg. his first dose was received at 4 p.m. he tolerated the two medications without incident. his blood pressure remained stable. he denied any nausea, vomiting or diarrhea. he had no skin flushing. he had a temperature of 101.2 several hours after the initial interferon. at time of discharge, he was afebrile. he was otherwise without complaint tolerating good po intake. he had no appreciable toxicities. the learning center came and instructed him on the use of subcutaneous injections of il-2. he was discharged on il-2 and instructed to use 9 million units subcutaneously five days a week times four a week, each dose given at 6 p.m. wednesday through sunday. he will receive peg-intron on a weekly basis in clinic. , m.d. dictated by: medquist36 procedure: partial nephrectomy diagnoses: malignant neoplasm of kidney, except pelvis secondary malignant neoplasm of lung 

Answer: The patient is high likely exposed to